Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Operating Margin (2023 - 2025)

Mangoceuticals' Operating Margin history spans 3 years, with the latest figure at 389.72% for Q4 2025.

  • On a quarterly basis, Operating Margin fell 463289.0% to 389.72% in Q4 2025 year-over-year; TTM through Dec 2025 was 3954.28%, a 365738.0% decrease, with the full-year FY2025 number at 3954.28%, down 365738.0% from a year prior.
  • Operating Margin hit 389.72% in Q4 2025 for Mangoceuticals, up from 8953.45% in the prior quarter.
  • Over the last five years, Operating Margin for MGRX hit a ceiling of 4243.18% in Q4 2024 and a floor of 8953.45% in Q3 2025.
  • Historically, Operating Margin has averaged 1864.65% across 3 years, with a median of 1323.67% in 2024.
  • Biggest five-year swings in Operating Margin: surged 529404bps in 2024 and later tumbled -763524bps in 2025.
  • Tracing MGRX's Operating Margin over 3 years: stood at 1050.87% in 2023, then skyrocketed by 504bps to 4243.18% in 2024, then plummeted by -109bps to 389.72% in 2025.
  • Business Quant data shows Operating Margin for MGRX at 389.72% in Q4 2025, 8953.45% in Q3 2025, and 3133.98% in Q2 2025.